TY - JOUR
T1 - Imaging Features of Primary Intracranial Sarcoma with DICER1 Mutation
T2 - A Multicenter Case Series
AU - Eldaya, Rami
AU - Fagan, Richard J.
AU - Dagher, Samir A.
AU - Roy, Angshumoy
AU - Dahyia, Sonika
AU - Fuller, Gregory N.
AU - Wintermark, Max
AU - Parsons, Matthew S.
AU - Huisman, Thierry A.G.M.
N1 - Publisher Copyright:
© 2024 American Society of Neuroradiology. All rights reserved.
PY - 2024/5/1
Y1 - 2024/5/1
N2 - Primary intracranial sarcoma, DICER1-mutant, is a rare, recently described entity in the fifth edition of the WHO Classification of CNS Tumors. Given the entity’s rarity and recent description, imaging data on primary intracranial sarcoma, DICER1-mutant, remains scarce. In this multicenter case series, we present detailed multimodality imaging features of primary intracranial sarcoma, DICER1-mutant, with emphasis on the appearance of the entity on MR imaging. In total, 8 patients were included. In all 8 patients, the lesion demonstrated blood products on T1WI. In 7 patients, susceptibility-weighted imaging was obtained and demonstrated blood products. Primary intracranial sarcoma, DICER1-mutant, is a CNS neoplasm that primarily affects pediatric and young adult patients. In the present case series, we explore potential imaging findings that are helpful in suggesting this diagnosis. In younger patients, the presence of a cortical lesion with intralesional blood products on SWI and T1-weighted MR imaging, with or without extra-axial blood products, should prompt the inclusion of this entity in the differential diagnosis.
AB - Primary intracranial sarcoma, DICER1-mutant, is a rare, recently described entity in the fifth edition of the WHO Classification of CNS Tumors. Given the entity’s rarity and recent description, imaging data on primary intracranial sarcoma, DICER1-mutant, remains scarce. In this multicenter case series, we present detailed multimodality imaging features of primary intracranial sarcoma, DICER1-mutant, with emphasis on the appearance of the entity on MR imaging. In total, 8 patients were included. In all 8 patients, the lesion demonstrated blood products on T1WI. In 7 patients, susceptibility-weighted imaging was obtained and demonstrated blood products. Primary intracranial sarcoma, DICER1-mutant, is a CNS neoplasm that primarily affects pediatric and young adult patients. In the present case series, we explore potential imaging findings that are helpful in suggesting this diagnosis. In younger patients, the presence of a cortical lesion with intralesional blood products on SWI and T1-weighted MR imaging, with or without extra-axial blood products, should prompt the inclusion of this entity in the differential diagnosis.
UR - http://www.scopus.com/inward/record.url?scp=85192845629&partnerID=8YFLogxK
U2 - 10.3174/ajnr.A8192
DO - 10.3174/ajnr.A8192
M3 - Article
C2 - 38637027
AN - SCOPUS:85192845629
SN - 0195-6108
VL - 45
SP - 626
EP - 631
JO - American Journal of Neuroradiology
JF - American Journal of Neuroradiology
IS - 5
ER -